TY - JOUR
KW - algorithm
KW - Amyotrophic lateral sclerosis
KW - epidemiology
KW - U.S. Claims
KW - UK primary care
AU - A. Abbasi
AU - H. Fryk
AU - J. Rudnik
AU - R. White
AU - M. Vanderkelen
AU - A. Scowcroft
AU - K. Bonar
AD - UCB Pharma Ltd., 208 Bath Road, Slough, SL1 3WE, UK. ali.abbasi@ucb.com.
UCB Pharma Ltd., 208 Bath Road, Slough, SL1 3WE, UK.
UCB Pharma, Raleigh, USA.
UCB Pharma, Braine, Belgium.
AN - 38270730
BT - Neurol Sci
DO - 10.1007/s10072-024-07336-8
DP - NLM
ET - 2024/01/25
LA - eng
N1 - 1590-3478
Abbasi, Ali
Orcid: 0000-0002-6452-4765
Fryk, Henrik
Rudnik, Jan
White, Richard
Vanderkelen, Mark
Scowcroft, Anna
Bonar, Kerina
Journal Article
Italy
Neurol Sci. 2024 Jan 25. doi: 10.1007/s10072-024-07336-8.
PY - 2024
SN - 1590-1874
T2 - Neurol Sci
TI - Using an expanded algorithm to estimate prevalence of amyotrophic lateral sclerosis in U.S. and UK
ER -